International Journal of
Reproductive Biomedicine
Mon, Dec 30, 2024
[Archive]
Volume 22, Issue 10 (October 2024)
IJRM 2024, 22(10): 811-820 |
Back to browse issues page
Ethics code: IR.MODARES.REC.1399.162
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Haghipour Z, Jahanian Sadatmahalleh S, Razavinia F, Nasiri M. Association between menstrual disorders and anti-Müllerian hormone with COVID-19: A prospective cohort study. IJRM 2024; 22 (10) :811-820
URL: http://ijrm.ir/article-1-3223-en.html
URL: http://ijrm.ir/article-1-3223-en.html
1- Department of Reproductive Health and Midwifery, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
2- Department of Reproductive Health and Midwifery, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran. ,Shahideh.Jahanian@modares.ac.ir
3- Midwifery Department, Reproductive Health Promotion Research Center, Nursing and Midwifery School, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
4- Department of Basic Sciences, Faculty of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
2- Department of Reproductive Health and Midwifery, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran. ,
3- Midwifery Department, Reproductive Health Promotion Research Center, Nursing and Midwifery School, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
4- Department of Basic Sciences, Faculty of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Abstract: (140 Views)
Background: Coronavirus 2019 (COVID-19) has affected almost all communities throughout the world. It affects different systems in the body, which causes irreparable consequences.
Objective: This study aimed to investigate the effect of the COVID-19 virus on menstrual disorders, anti-Mullerian hormone (AMH), thyroid peroxidase (TPO), thyroid stimulating hormone (TSH), and prolactin levels in women with COVID-19 disease.
Materials and Methods: This prospective cohort study was conducted on 201 women (101 healthy, and 100 women with COVID-19) in Nomadic hospital, Khorramabad, Iran from February-October 2021. After recovery from COVID-19, participants were interviewed about their menstrual cycle in their 1st and 4th months. Blood samples were collected during 1st and 4th months, and AMH, TSH, TPO, and prolactin levels were assessed.
Results: No significant differences were observed in the 1st and 4th months regarding menstrual disorders, TPO, and prolactin levels in the patient group (p > 0.05). The mean level of AMH in the healthy group was higher than the patient group in both times (p < 0.001). A relationship between TSH and COVID-19 was observed in the 1st month (p < 0.001); however, no significant relationship was observed in the 4th month, in this regard.
Conclusion: Endocrine dysfunction in the form of low AMH and high TSH were common among COVID-19 patients. Due to the importance of menstrual and hormonal disorders, especially AMH and TSH, and their association with COVID-19, health policymakers should find appropriate solutions to reduce complications.
Objective: This study aimed to investigate the effect of the COVID-19 virus on menstrual disorders, anti-Mullerian hormone (AMH), thyroid peroxidase (TPO), thyroid stimulating hormone (TSH), and prolactin levels in women with COVID-19 disease.
Materials and Methods: This prospective cohort study was conducted on 201 women (101 healthy, and 100 women with COVID-19) in Nomadic hospital, Khorramabad, Iran from February-October 2021. After recovery from COVID-19, participants were interviewed about their menstrual cycle in their 1st and 4th months. Blood samples were collected during 1st and 4th months, and AMH, TSH, TPO, and prolactin levels were assessed.
Results: No significant differences were observed in the 1st and 4th months regarding menstrual disorders, TPO, and prolactin levels in the patient group (p > 0.05). The mean level of AMH in the healthy group was higher than the patient group in both times (p < 0.001). A relationship between TSH and COVID-19 was observed in the 1st month (p < 0.001); however, no significant relationship was observed in the 4th month, in this regard.
Conclusion: Endocrine dysfunction in the form of low AMH and high TSH were common among COVID-19 patients. Due to the importance of menstrual and hormonal disorders, especially AMH and TSH, and their association with COVID-19, health policymakers should find appropriate solutions to reduce complications.
Type of Study: Original Article |
Subject:
Reproductive Endocrinology
References
1. Kılçar M, Turgut ÜK, Bozkurt KK, Bayhan G. Effects of permanent placental injury due to severe acute respiratory syndrome coronavirus 2 infection during pregnancy on the feto-placental circulation: A cross-sectional study. Rev Assoc Med Bras 2024; 70: e20230827. [DOI:10.1590/1806-9282.20230827] [PMID] [PMCID]
2. Joshi S, Bhatia A, Tayal N, Jha LK, Gupta P. Rare multisystem inflammatory syndrome in young adult after COVID-19 immunization and subsequent SARSCoV-2 infection. J Assoc Physicians India 2022; 69: 11-12.
3. Sharma I, Kumari P, Sharma A, Saha SC. SARS-CoV-2 and the reproductive system: Known and the unknown! Middle East Fertil Soc J 2021; 26: 1-9. [DOI:10.1186/s43043-020-00046-z] [PMID] [PMCID]
4. Zhang H, Li H-B, Lyu J-R, Lei X-M, Li W, Wu G, et al. Specific ACE2 expression in small intestinal enterocytes may cause gastrointestinal symptoms and injury after 2019-nCoV infection. Int J Infect Dis 2020; 96: 19-24. [DOI:10.1016/j.ijid.2020.04.027] [PMID] [PMCID]
5. Athar F, Karmani M, Templeman NM. Metabolic hormones are integral regulators of female reproductive health and function. Biosci Rep 2024; 44: BSR20231916. [DOI:10.1042/BSR20231916] [PMID] [PMCID]
6. Ma L, Xie W, Li D, Shi L, Mao Y, Xiong Y, et al. Effect of SARS-CoV-2 infection upon male gonadal function: A single center-based study. MedRxiv 2020. (Preprint) [DOI:10.1101/2020.03.21.20037267]
7. Ding T, Zhang J, Wang T, Cui P, Chen Z, Jiang J, et al. Potential influence of menstrual status and sex hormones on female severe acute respiratory syndrome coronavirus 2 infection: A cross-sectional multicenter study in Wuhan, China. Clin Infect Dis 2021; 72: e240-e248. [DOI:10.1093/cid/ciaa1022] [PMID] [PMCID]
8. Li H, Liu S-M, Yu X-H, Tang S-L, Tang C-K. Coronavirus disease 2019 (COVID-19): Current status and future perspectives. Int J Antimicrob Agents 2020; 55: 105951. [DOI:10.1016/j.ijantimicag.2020.105951] [PMID] [PMCID]
9. Honorato‐Sampaio K, Pereira VM, Santos RA, Reis AM. Evidence that angiotensin‐(1-7) is an intermediate of gonadotrophin‐induced oocyte maturation in the rat preovulatory follicle. Exp Physiol 2012; 97: 642-650. [DOI:10.1113/expphysiol.2011.061960] [PMID]
10. Stanton R, To QG, Khalesi S, Williams SL, Alley SJ, Thwaite TL, et al. Depression, anxiety and stress during COVID-19: Associations with changes in physical activity, sleep, tobacco and alcohol use in Australian adults. Int J Environ Res Public Health 2020; 17: 4065. [DOI:10.3390/ijerph17114065] [PMID] [PMCID]
11. Song S, Choi H, Pang Y, Kim O, Park H-Y. Factors associated with regularity and length of menstrual cycle: Korea nurses' health study. BMC Women's Health 2022; 22: 361. [DOI:10.1186/s12905-022-01947-z] [PMID] [PMCID]
12. Anto-Ocrah M, Valachovic T, Chen M, Tiffany K, DeSplinter L, Kaukeinen K, et al. Coronavirus disease 2019 (COVID-19)-related stress and menstrual changes. Obstet Gynecol 2023; 141: 176-187. [DOI:10.1097/AOG.0000000000005010] [PMID] [PMCID]
13. Lee W, Mok A, Chung JP. Potential effects of COVID-19 on reproductive systems and fertility; assisted reproductive technology guidelines and considerations: A review. Hong Kong Med J 2021; 27: 118. [DOI:10.12809/hkmj209078] [PMID]
14. Liu C, Mu C, Zhang Q, Yang X, Yan H, Jiao H. Effects of infection with SARS-CoV-2 on the male and female reproductive systems: A review. Med Sci Monit 2021; 27: e930168. [DOI:10.12659/MSM.930168]
15. Edlow AG, Li JZ, Ai-ris YC, Atyeo C, James KE, Boatin AA, et al. Assessment of maternal and neonatal SARS-CoV-2 viral load, transplacental antibody transfer, and placental pathology in pregnancies during the COVID-19 pandemic. JAMA Netw Open 2020; 3: e2030455. [DOI:10.1001/jamanetworkopen.2020.30455] [PMID] [PMCID]
16. Reid PC, Coker A, Coltart R. Assessment of menstrual blood loss using a pictorial chart: A validation study. BJOG 2000; 107: 320-322. [DOI:10.1111/j.1471-0528.2000.tb13225.x] [PMID]
17. Darney BG, Boniface ER, Van Lamsweerde A, Han L, Matteson KA, Cameron S, et al. Impact of coronavirus disease 2019 (COVID‐19) vaccination on menstrual bleeding quantity: An observational cohort study. BJOG 2023; 130: 803-812. [DOI:10.1111/1471-0528.17471] [PMID]
18. Kanwal M, Irfani I, Afzal N, Saba E, Dahar A. Awareness, perceptions and future plan for bbilateral tubal ligation as a method for contraception in Pakistani women. J Soc Obstet Gynaecol Pak 2023; 13: 338-343.
19. Karena ZV, Shah H, Vaghela H, Chauhan K, Desai PK, Chitalwala AR, et al. Clinical utility of mifepristone: Apprising the expanding horizons. Cureus 2022; 14: e28318. [DOI:10.7759/cureus.28318]
20. Edelman A, Boniface ER, Benhar E, Han L, Matteson KA, Favaro C, et al. Association between menstrual cycle length and coronavirus disease 2019 (COVID-19) vaccination: A US cohort. Obstet Gynecol 2022; 139: 481-489. [DOI:10.1097/AOG.0000000000004695] [PMID] [PMCID]
21. Li Kezhen, Chen G, Hou H, Liao Q, Chen J, Bai H, et al. Analysis of sex hormones and menstruation in COVID-19 women of child-bearing age. Reprod Biomed Online 2021; 42: 260-267. [DOI:10.1016/j.rbmo.2020.09.020] [PMID] [PMCID]
22. Khan SM, Shilen A, Heslin KM, Ishimwe P, Allen AM, Jacobs ET, et al. SARS-CoV-2 infection and subsequent changes in the menstrual cycle among participants in the Arizona CoVHORT study. Am J Obstet Gynecol 2022; 226: 270-273. [DOI:10.1016/j.ajog.2021.09.016] [PMID] [PMCID]
23. Ozimek N, Velez K, Anvari H, Butler L, Goldman KN, Woitowich NC. Impact of stress on menstrual cyclicity during the coronavirus disease 2019 pandemic: A survey study. J Women's Health 2022; 31: 84-90. [DOI:10.1089/jwh.2021.0158] [PMID]
24. Ding T, Wang T, Zhang J, Cui P, Chen Z, Zhou S, et al. Analysis of ovarian injury associated with COVID-19 disease in reproductive-aged women in Wuhan, China: An observational study. Front Med 2021; 8: 635255. [DOI:10.3389/fmed.2021.635255] [PMID] [PMCID]
25. Yeğin GF, Desdicioğlu R, Seçen Eİ, Aydın S, Bal C, Göka E, et al. Low anti-Mullerian hormone levels are associated with the severity of anxiety experienced by healthcare professionals during the COVID-19 pandemic. Reprod Sci 2022; 29: 627-632. [DOI:10.1007/s43032-021-00643-x] [PMID] [PMCID]
26. Yanachkova V, Stankova T, Staynova R. Thyroid dysfunction as a long-term post-COVID-19 complication in mild-to-moderate COVID-19. Biotech Biotechnol Equip 2023; 37: 194-202. [DOI:10.1080/13102818.2023.2170829]
27. Khoo B, Tan T, Clarke SA, Mills EG, Patel B, Modi M, et al. Thyroid function before, during, and after COVID-19. J Clin Endocrinol Metab 2021; 106: e803-e811. [DOI:10.1210/clinem/dgaa830] [PMID] [PMCID]
28. Tsivgoulis G, Fragkou PC, Karofylakis E, Paneta M, Papathanasiou K, Palaiodimou L, et al. Hypothyroidism is associated with prolonged COVID-19-induced anosmia: A case-control study. J Neurol Neurosurg Psychiatry 2021; 92: 911-912. [DOI:10.1136/jnnp-2021-326587] [PMID]
29. Mohammed AH, Yousif AM, Jabbar SA, Ismail PA. Assessment of thyroid function in COVID-19 patients. Tabari Biomed Stu Res J 2021; 3: 8-13. [DOI:10.18502/tbsrj.v3i3.6930]
30. de Noriega Echevarría I, García-Salido A, Muñoz-Calvo MT, Argente J. Elevated thyroid hormone levels following low molecular weight heparin administration. An Pediatr (Barc) 2017; 87: 50-53. [DOI:10.1016/j.anpedi.2016.09.006] [PMID]
31. Burekovic A, Halilovic D, Sahbaz A. Hypothyroidism and subclinical hypothyroidism as a consequence of COVID-19 infection. Med Arch 2022; 76: 12-16. [DOI:10.5455/medarh.2022.76.12-16] [PMID] [PMCID]
32. Chaudhuri A, Koner S. A study of correlation of perceived stress with serum prolactin levels in newly diagnosed cases of hypothyroidism in females in an Urban population of a developing country. Int J Res Rev 2018; 5: 154-162.
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
